SlideShare uma empresa Scribd logo
1 de 16
Baixar para ler offline
Developing Better Assays for
   Every Human Protein

 OriGene Technologies, Inc.

          Mark E. Watson
Sr. Director Business Development
       Phone: (240)994-6873
  Email: mwatson@origene.com
Collaboration Opportunities with OriGene

   • Strategic Licensing Agreements
   • Supply agreement for cDNA clones, full-length human
   proteins and validated monoclonal antibodies
       -Purchase of full cDNA clone collection or subsets
       -Human and Mouse ORF clones available
       -Bulk full-length protein development
       -Licensing of hybridoma cell lines (e.g. TrueMAB mAbs)
       -Joint mAb and/or Hybridoma cell line development
       -Custom multiplex assay development

   • Collaboration agreements for antibody decoding and auto-
   antibody studies using the proprietary protein lysate microarray
   technology from OriGene

   • Custom service projects leveraging gene synthesis
   capabilities from Blue Heron Biotechnology, including codon &
   antibody optimization
OriGene’s Key Capabilities
 • Largest collection of cDNA clones in the world
 • Protein production in human cells
    –   12,000 transfected antigen lysates
    –   5,000 purified proteins from HEK293Tcells
    –   Est.10,000 available by the end of 2011
    –   Heavy-labeled MRM/Mass spec. standards.
 • High throughput mAb production/ validation
    – Recently opened second facility to expand production to over 500 released and fully
      validated mAbs/month
    – Three fold increase in production capabilities by year end 2011
 • Cytomyx tissue bank:
    – >140,000 tissue samples
    – High throughput IHC validation capabilities
 • Synthetic Gene Production & Services
    – Blue Heron Biotechnology Acquisition (Ab & Codon optimization)
 • 10,000 Antigen Chip (Autoimmune & Cancer tests)
 • Luminex multiplex assay development (Marligen acquisition)
Complete Gene/clone Resource




  TrueORF/Gold         True Proteins          TrueMAB               TruePlex
  Human/mouse          5,000 human            >1,800 mAbs
  Expression vectors   Custom purification    IHC, IF, IP, FC, WB


   Clones/genes            Proteins             Antibodies             Assays


  Any species          Optimized             Antibody engineering   Multiplex Assays
  Any sequences        expression
  Any variants
High Throughput Work Flow

   Transient Transfection     Cell Lysates            Affinity
        (MegaTran)                                    Column



        15,000                      12,000                             5,000
    TrueORF Clones          Over-expression Lysates              Purified Protein




     Largest offering of mammalian cell expressed human proteins
Highest Quality Standard


 Not just sequence-verification

 But also,

 Expression Validation on 12,000 TrueORF clones




 APO3C                 TP53                  ENC1                  CDH3                  LRP1
 TrueORF:RC206566      TrueORF:RC200003      TrueORF:RC201842      TrueORF:RC207346      TrueORF:RC218369
 ORF size: 300 bp      ORF size: 1182 bp     ORF size: 1770 bp     ORF size: 2490 bp     ORF size: 13635 bp
 Predicted MW: 11 kd   Predicted MW: 53 kd   Predicted MW: 65 kd   Predicted MW: 91 kd   Predicted MW: 504 kd
Transfected Over-Expression Lysates

  • 12,000 TrueORF clone transfected HEK293T cell lysates

  • Mammalian cell expressed full length, WB validated

  • Delivered in modified RIPA buffer to preserve protein function

  • Ideal tools for antibody validation, protein function studies, and
    as assay standards
Over-expression Lysates




  • OriGene over-expression lysates adopted in Antibody Atlas Program to
  validate polyclonal antibodies (e.g. Atlas Antibodies).

  • Improved validation success rate from 32% with regular cell lysates to 89% with over-
  expression lysates.

  • Data from Prof Mathias Uhlén, Program Director.
10,000 Lysate Protein Arrays

                                                                  E-Cadherin1




                                                         Enlarged image



     Anti-DDK (Rabbit)       Anti-E-Cadherin1 (mAb)

  Using OriGene antigen microarray chip technology
  to decode antibodies that were generated by whole cell immunization
Full Length Human Proteins


• Produced from TrueORF cDNA
  clones

• 5,000 full length human proteins

• Expressed in HEK293 cells

• Optimal preservation of protein
  structure, post-translational
  modifications and functions
Human Protein Activity

                                               mTOR Activity Assay

                                               Homogeneous time-resolved
                                                  fluorescent (HTRF®) assay.

                                               mTOR is a serine/threonine
                                                  protein kinase that regulates
                                                  cell growth, cell proliferation,
                                                  cell motility, cell survival,
                                                  protein synthesis, and
                                                  transcription. mTOR
                                                  belongs to the
                                                  phosphatidylinositol 3-
                                                  kinase-related kinase protein
                                                  family.




    First commercial provider of active, full-length human mTOR protein
MS Collaboration with ISB

 • Generate signature peptide sequences for all 5,000
   human proteins
    – Sequences will be in PeptideAtlas database

 • Heavy-isotope labeled purified proteins
    – 5,000 available now for SRM/MRM application

 • Isotope labeled peptides
    – Coming in 2011 for all 5,000 human protein
mAbs for Every Human Protein


                     Dedicated mAb production center
                       - Capacity: +200 immunizations per month

                     Authentic proteins as antigens
                       - Full length proteins made in human cells

                     Extensive validation
                       -   WB: 9 different cell lines
                       -   IHC: 24 different tissues
                       -   IF
                       -   Flow cytometry
                       -   Luminex
                       -   Additional validation available


                     Hybridoma cell lines for licensing
                       - High value targets available: ERCC1, LGR5,
                         HES1 & NOTCH1


                  Goal: To produce high quality mAbs
                  to every human proteins in 5-10
                  years
HTP Validation of mAbs




      Anti-KRT WB with OriGene                Anti-KRT WB with cell panel of 9 different cell lines
      over expression lysate                  (For endogenous protein detection in cell line)




  ERCC1 (1A3)                ERCC1 (4F9)
                                             IF data with A549 cells   IF data with A549 cells
 IHC data for human carcinoma liver tissue
Immunoassay Development

                                           Quantitation of 6 Growth Factors in an 11-plex ELISA
                               30000


                                               FGF -4
                               25000
Median Fluorescent Intensity




                                               VEGF -D

                                               EGF
                               20000
                                               HGF

                                               PlGF
                               15000
                                               VEGF -A


                               10000



                               5000



                                  0
                                       1                 10                  100              1000   10000

                                                              Analyte Concentration (pg/ml)
Summary

  OriGene has developed the most comprehensive
   genome wide product solutions available

  Leading developer of high quality reagents and
  multiplex assays for every human protein

  OriGene is your perfect partner for companion
   diagnostic and biomarker assay development

  Additional information available at:

                      www.origene.com

Mais conteúdo relacionado

Mais procurados

Cupid Peptides presentation wjr
Cupid Peptides presentation wjrCupid Peptides presentation wjr
Cupid Peptides presentation wjrCupid Peptides
 
Recombinant yeast technology at the cutting edge robust tools for both design...
Recombinant yeast technology at the cutting edge robust tools for both design...Recombinant yeast technology at the cutting edge robust tools for both design...
Recombinant yeast technology at the cutting edge robust tools for both design...NavPrabh Sandhu Johal
 
Combined thesis 1
Combined thesis 1Combined thesis 1
Combined thesis 1deepthesis
 
Generation of MRP2 Efflux Transporter Knock-Out in HepaRG Cell Line
Generation of MRP2 Efflux Transporter Knock-Out in HepaRG Cell LineGeneration of MRP2 Efflux Transporter Knock-Out in HepaRG Cell Line
Generation of MRP2 Efflux Transporter Knock-Out in HepaRG Cell Linemdmitc
 
Next generation biotherapeutics production system Trichoderma reesei
Next generation biotherapeutics production system Trichoderma reeseiNext generation biotherapeutics production system Trichoderma reesei
Next generation biotherapeutics production system Trichoderma reeseiChristopher Landowski
 
Regulation of embryonic stem cell pluripotency by heat
Regulation of embryonic stem cell pluripotency by heatRegulation of embryonic stem cell pluripotency by heat
Regulation of embryonic stem cell pluripotency by heatMahmoud El Beblawy
 
Enabling Cancer Immunotherapy: From Discovery to Combinations
Enabling Cancer Immunotherapy: From Discovery to CombinationsEnabling Cancer Immunotherapy: From Discovery to Combinations
Enabling Cancer Immunotherapy: From Discovery to CombinationsDiscoverX Corporation
 
Production of recombinent proteins, faisal munir
Production of recombinent proteins, faisal munirProduction of recombinent proteins, faisal munir
Production of recombinent proteins, faisal munirNoman-Hafeez khosa
 
Culture of Renal Proximal Tubule Epithelial Cell Line SA7K Using Extracellula...
Culture of Renal Proximal Tubule Epithelial Cell Line SA7K Using Extracellula...Culture of Renal Proximal Tubule Epithelial Cell Line SA7K Using Extracellula...
Culture of Renal Proximal Tubule Epithelial Cell Line SA7K Using Extracellula...mdmitc
 
Ttp Lab Tech Talk 051810
Ttp Lab Tech Talk 051810Ttp Lab Tech Talk 051810
Ttp Lab Tech Talk 051810Neil Kubica
 
Innate immunity 2013
Innate immunity 2013Innate immunity 2013
Innate immunity 2013Elsa von Licy
 
Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...bioejjournal
 
Derivation and functional characterization of distinct dc subsets
Derivation and functional characterization of distinct dc subsetsDerivation and functional characterization of distinct dc subsets
Derivation and functional characterization of distinct dc subsetsOfer Wellisch
 
1015893 IAS characterization poster v10, final 071415
1015893 IAS characterization poster v10, final 0714151015893 IAS characterization poster v10, final 071415
1015893 IAS characterization poster v10, final 071415Ira Dicker
 

Mais procurados (20)

Cupid Peptides presentation wjr
Cupid Peptides presentation wjrCupid Peptides presentation wjr
Cupid Peptides presentation wjr
 
Recombinant yeast technology at the cutting edge robust tools for both design...
Recombinant yeast technology at the cutting edge robust tools for both design...Recombinant yeast technology at the cutting edge robust tools for both design...
Recombinant yeast technology at the cutting edge robust tools for both design...
 
Aacr2009 chip
Aacr2009 chipAacr2009 chip
Aacr2009 chip
 
Combined thesis 1
Combined thesis 1Combined thesis 1
Combined thesis 1
 
Generation of MRP2 Efflux Transporter Knock-Out in HepaRG Cell Line
Generation of MRP2 Efflux Transporter Knock-Out in HepaRG Cell LineGeneration of MRP2 Efflux Transporter Knock-Out in HepaRG Cell Line
Generation of MRP2 Efflux Transporter Knock-Out in HepaRG Cell Line
 
Next generation biotherapeutics production system Trichoderma reesei
Next generation biotherapeutics production system Trichoderma reeseiNext generation biotherapeutics production system Trichoderma reesei
Next generation biotherapeutics production system Trichoderma reesei
 
Regulation of embryonic stem cell pluripotency by heat
Regulation of embryonic stem cell pluripotency by heatRegulation of embryonic stem cell pluripotency by heat
Regulation of embryonic stem cell pluripotency by heat
 
Enabling Cancer Immunotherapy: From Discovery to Combinations
Enabling Cancer Immunotherapy: From Discovery to CombinationsEnabling Cancer Immunotherapy: From Discovery to Combinations
Enabling Cancer Immunotherapy: From Discovery to Combinations
 
Kwon et al 2007 jbs
Kwon et al 2007 jbsKwon et al 2007 jbs
Kwon et al 2007 jbs
 
Poster presentation Final
Poster presentation FinalPoster presentation Final
Poster presentation Final
 
Production of recombinent proteins, faisal munir
Production of recombinent proteins, faisal munirProduction of recombinent proteins, faisal munir
Production of recombinent proteins, faisal munir
 
Cristina Clement L08 presentation YI APS 2015 Orlando Florida
Cristina Clement L08 presentation YI APS 2015 Orlando FloridaCristina Clement L08 presentation YI APS 2015 Orlando Florida
Cristina Clement L08 presentation YI APS 2015 Orlando Florida
 
Culture of Renal Proximal Tubule Epithelial Cell Line SA7K Using Extracellula...
Culture of Renal Proximal Tubule Epithelial Cell Line SA7K Using Extracellula...Culture of Renal Proximal Tubule Epithelial Cell Line SA7K Using Extracellula...
Culture of Renal Proximal Tubule Epithelial Cell Line SA7K Using Extracellula...
 
Ttp Lab Tech Talk 051810
Ttp Lab Tech Talk 051810Ttp Lab Tech Talk 051810
Ttp Lab Tech Talk 051810
 
Innate immunity 2013
Innate immunity 2013Innate immunity 2013
Innate immunity 2013
 
Recombinant growth factors
Recombinant growth factorsRecombinant growth factors
Recombinant growth factors
 
Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...
 
Derivation and functional characterization of distinct dc subsets
Derivation and functional characterization of distinct dc subsetsDerivation and functional characterization of distinct dc subsets
Derivation and functional characterization of distinct dc subsets
 
1015893 IAS characterization poster v10, final 071415
1015893 IAS characterization poster v10, final 0714151015893 IAS characterization poster v10, final 071415
1015893 IAS characterization poster v10, final 071415
 
The Phantom Menace
The Phantom MenaceThe Phantom Menace
The Phantom Menace
 

Destaque

HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...Candy Smellie
 
Do i have skin cancer?
Do i have skin cancer?Do i have skin cancer?
Do i have skin cancer?raneetaylor
 
Xmatrx ELITE
Xmatrx ELITEXmatrx ELITE
Xmatrx ELITEBioGenex
 
Genomics and proteomics I
Genomics and proteomics IGenomics and proteomics I
Genomics and proteomics INikolay Vyahhi
 
qPCR Diagnostics Assay Development for Infectious Disease Working with Indust...
qPCR Diagnostics Assay Development for Infectious Disease Working with Indust...qPCR Diagnostics Assay Development for Infectious Disease Working with Indust...
qPCR Diagnostics Assay Development for Infectious Disease Working with Indust...Jonathan Clarke
 
Big Data and Genomic Medicine by Corey Nislow
Big Data and Genomic Medicine by Corey NislowBig Data and Genomic Medicine by Corey Nislow
Big Data and Genomic Medicine by Corey NislowKnome_Inc
 
Genomics and proteomics by shreeman
Genomics and proteomics by shreemanGenomics and proteomics by shreeman
Genomics and proteomics by shreemanshreeman cs
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and developmentrahul_pharma
 

Destaque (13)

HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
 
Do i have skin cancer?
Do i have skin cancer?Do i have skin cancer?
Do i have skin cancer?
 
Xmatrx ELITE
Xmatrx ELITEXmatrx ELITE
Xmatrx ELITE
 
Genomics and proteomics I
Genomics and proteomics IGenomics and proteomics I
Genomics and proteomics I
 
qPCR Diagnostics Assay Development for Infectious Disease Working with Indust...
qPCR Diagnostics Assay Development for Infectious Disease Working with Indust...qPCR Diagnostics Assay Development for Infectious Disease Working with Indust...
qPCR Diagnostics Assay Development for Infectious Disease Working with Indust...
 
Big Data and Genomic Medicine by Corey Nislow
Big Data and Genomic Medicine by Corey NislowBig Data and Genomic Medicine by Corey Nislow
Big Data and Genomic Medicine by Corey Nislow
 
Genomics and proteomics by shreeman
Genomics and proteomics by shreemanGenomics and proteomics by shreeman
Genomics and proteomics by shreeman
 
Proteomics
Proteomics Proteomics
Proteomics
 
Proteomics
ProteomicsProteomics
Proteomics
 
Proteomics ppt
Proteomics pptProteomics ppt
Proteomics ppt
 
Proteomics
ProteomicsProteomics
Proteomics
 
Genomics
GenomicsGenomics
Genomics
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and development
 

Semelhante a OriGene Technologies Capabilities Overview Feb 2011

FFPE Applications Solutions brochure
FFPE Applications Solutions brochureFFPE Applications Solutions brochure
FFPE Applications Solutions brochureAffymetrix
 
MAMMALIAN CELL EXPRESSION SYSTEM, STRONG PROMOTERS.pptx
MAMMALIAN CELL EXPRESSION SYSTEM, STRONG PROMOTERS.pptxMAMMALIAN CELL EXPRESSION SYSTEM, STRONG PROMOTERS.pptx
MAMMALIAN CELL EXPRESSION SYSTEM, STRONG PROMOTERS.pptxSarah Hamid
 
Integrating arrays and RNA-Seq
Integrating arrays and RNA-Seq Integrating arrays and RNA-Seq
Integrating arrays and RNA-Seq Affymetrix
 
Mammalian & Bacterial Expression
Mammalian & Bacterial ExpressionMammalian & Bacterial Expression
Mammalian & Bacterial ExpressionJesús C. Morales
 
One-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBioOne-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBioGenScript ProBio
 
2017 molecular profiling_wim_vancriekinge
2017 molecular profiling_wim_vancriekinge2017 molecular profiling_wim_vancriekinge
2017 molecular profiling_wim_vancriekingeProf. Wim Van Criekinge
 
Microarrays;application
Microarrays;applicationMicroarrays;application
Microarrays;applicationFyzah Bashir
 
CrossGen-Merck manuscript
CrossGen-Merck manuscriptCrossGen-Merck manuscript
CrossGen-Merck manuscriptKush Sharma
 
Spotlight on ipsc reprogramming
Spotlight on ipsc reprogrammingSpotlight on ipsc reprogramming
Spotlight on ipsc reprogrammingCreative-Bioarray
 
Spotlight on i psc reprogramming
Spotlight on i psc reprogrammingSpotlight on i psc reprogramming
Spotlight on i psc reprogrammingCreative-Bioarray
 
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...QIAGEN
 
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel...
 Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel... Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel...
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel...Qiagen - Egypt
 
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...Thermo Fisher Scientific
 

Semelhante a OriGene Technologies Capabilities Overview Feb 2011 (20)

FFPE Applications Solutions brochure
FFPE Applications Solutions brochureFFPE Applications Solutions brochure
FFPE Applications Solutions brochure
 
Multiplex Assays for Studying Gene Regulation and Cell Function
Multiplex Assays for Studying Gene Regulation and Cell FunctionMultiplex Assays for Studying Gene Regulation and Cell Function
Multiplex Assays for Studying Gene Regulation and Cell Function
 
MAMMALIAN CELL EXPRESSION SYSTEM, STRONG PROMOTERS.pptx
MAMMALIAN CELL EXPRESSION SYSTEM, STRONG PROMOTERS.pptxMAMMALIAN CELL EXPRESSION SYSTEM, STRONG PROMOTERS.pptx
MAMMALIAN CELL EXPRESSION SYSTEM, STRONG PROMOTERS.pptx
 
Qualify
QualifyQualify
Qualify
 
Integrating arrays and RNA-Seq
Integrating arrays and RNA-Seq Integrating arrays and RNA-Seq
Integrating arrays and RNA-Seq
 
Mammalian & Bacterial Expression
Mammalian & Bacterial ExpressionMammalian & Bacterial Expression
Mammalian & Bacterial Expression
 
One-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBioOne-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBio
 
2017 molecular profiling_wim_vancriekinge
2017 molecular profiling_wim_vancriekinge2017 molecular profiling_wim_vancriekinge
2017 molecular profiling_wim_vancriekinge
 
Exprssion vector
Exprssion vectorExprssion vector
Exprssion vector
 
rprotein
rproteinrprotein
rprotein
 
Making smarter choices on c dna clones
Making smarter choices on c dna clonesMaking smarter choices on c dna clones
Making smarter choices on c dna clones
 
Microarrays;application
Microarrays;applicationMicroarrays;application
Microarrays;application
 
CrossGen-Merck manuscript
CrossGen-Merck manuscriptCrossGen-Merck manuscript
CrossGen-Merck manuscript
 
2014 11 03_bioinformatics_case_studies
2014 11 03_bioinformatics_case_studies2014 11 03_bioinformatics_case_studies
2014 11 03_bioinformatics_case_studies
 
iPSC-derived Cardiomyocytes
iPSC-derived CardiomyocytesiPSC-derived Cardiomyocytes
iPSC-derived Cardiomyocytes
 
Spotlight on ipsc reprogramming
Spotlight on ipsc reprogrammingSpotlight on ipsc reprogramming
Spotlight on ipsc reprogramming
 
Spotlight on i psc reprogramming
Spotlight on i psc reprogrammingSpotlight on i psc reprogramming
Spotlight on i psc reprogramming
 
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cell...
 
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel...
 Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel... Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel...
Cell-based Reporter Assays: Measure 45 Signaling Pathway Activity in Any Cel...
 
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
 

OriGene Technologies Capabilities Overview Feb 2011

  • 1. Developing Better Assays for Every Human Protein OriGene Technologies, Inc. Mark E. Watson Sr. Director Business Development Phone: (240)994-6873 Email: mwatson@origene.com
  • 2. Collaboration Opportunities with OriGene • Strategic Licensing Agreements • Supply agreement for cDNA clones, full-length human proteins and validated monoclonal antibodies -Purchase of full cDNA clone collection or subsets -Human and Mouse ORF clones available -Bulk full-length protein development -Licensing of hybridoma cell lines (e.g. TrueMAB mAbs) -Joint mAb and/or Hybridoma cell line development -Custom multiplex assay development • Collaboration agreements for antibody decoding and auto- antibody studies using the proprietary protein lysate microarray technology from OriGene • Custom service projects leveraging gene synthesis capabilities from Blue Heron Biotechnology, including codon & antibody optimization
  • 3. OriGene’s Key Capabilities • Largest collection of cDNA clones in the world • Protein production in human cells – 12,000 transfected antigen lysates – 5,000 purified proteins from HEK293Tcells – Est.10,000 available by the end of 2011 – Heavy-labeled MRM/Mass spec. standards. • High throughput mAb production/ validation – Recently opened second facility to expand production to over 500 released and fully validated mAbs/month – Three fold increase in production capabilities by year end 2011 • Cytomyx tissue bank: – >140,000 tissue samples – High throughput IHC validation capabilities • Synthetic Gene Production & Services – Blue Heron Biotechnology Acquisition (Ab & Codon optimization) • 10,000 Antigen Chip (Autoimmune & Cancer tests) • Luminex multiplex assay development (Marligen acquisition)
  • 4. Complete Gene/clone Resource TrueORF/Gold True Proteins TrueMAB TruePlex Human/mouse 5,000 human >1,800 mAbs Expression vectors Custom purification IHC, IF, IP, FC, WB Clones/genes Proteins Antibodies Assays Any species Optimized Antibody engineering Multiplex Assays Any sequences expression Any variants
  • 5. High Throughput Work Flow Transient Transfection Cell Lysates Affinity (MegaTran) Column 15,000 12,000 5,000 TrueORF Clones Over-expression Lysates Purified Protein Largest offering of mammalian cell expressed human proteins
  • 6. Highest Quality Standard Not just sequence-verification But also, Expression Validation on 12,000 TrueORF clones APO3C TP53 ENC1 CDH3 LRP1 TrueORF:RC206566 TrueORF:RC200003 TrueORF:RC201842 TrueORF:RC207346 TrueORF:RC218369 ORF size: 300 bp ORF size: 1182 bp ORF size: 1770 bp ORF size: 2490 bp ORF size: 13635 bp Predicted MW: 11 kd Predicted MW: 53 kd Predicted MW: 65 kd Predicted MW: 91 kd Predicted MW: 504 kd
  • 7. Transfected Over-Expression Lysates • 12,000 TrueORF clone transfected HEK293T cell lysates • Mammalian cell expressed full length, WB validated • Delivered in modified RIPA buffer to preserve protein function • Ideal tools for antibody validation, protein function studies, and as assay standards
  • 8. Over-expression Lysates • OriGene over-expression lysates adopted in Antibody Atlas Program to validate polyclonal antibodies (e.g. Atlas Antibodies). • Improved validation success rate from 32% with regular cell lysates to 89% with over- expression lysates. • Data from Prof Mathias Uhlén, Program Director.
  • 9. 10,000 Lysate Protein Arrays E-Cadherin1 Enlarged image Anti-DDK (Rabbit) Anti-E-Cadherin1 (mAb) Using OriGene antigen microarray chip technology to decode antibodies that were generated by whole cell immunization
  • 10. Full Length Human Proteins • Produced from TrueORF cDNA clones • 5,000 full length human proteins • Expressed in HEK293 cells • Optimal preservation of protein structure, post-translational modifications and functions
  • 11. Human Protein Activity mTOR Activity Assay Homogeneous time-resolved fluorescent (HTRF®) assay. mTOR is a serine/threonine protein kinase that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, and transcription. mTOR belongs to the phosphatidylinositol 3- kinase-related kinase protein family. First commercial provider of active, full-length human mTOR protein
  • 12. MS Collaboration with ISB • Generate signature peptide sequences for all 5,000 human proteins – Sequences will be in PeptideAtlas database • Heavy-isotope labeled purified proteins – 5,000 available now for SRM/MRM application • Isotope labeled peptides – Coming in 2011 for all 5,000 human protein
  • 13. mAbs for Every Human Protein  Dedicated mAb production center - Capacity: +200 immunizations per month  Authentic proteins as antigens - Full length proteins made in human cells  Extensive validation - WB: 9 different cell lines - IHC: 24 different tissues - IF - Flow cytometry - Luminex - Additional validation available  Hybridoma cell lines for licensing - High value targets available: ERCC1, LGR5, HES1 & NOTCH1 Goal: To produce high quality mAbs to every human proteins in 5-10 years
  • 14. HTP Validation of mAbs Anti-KRT WB with OriGene Anti-KRT WB with cell panel of 9 different cell lines over expression lysate (For endogenous protein detection in cell line) ERCC1 (1A3) ERCC1 (4F9) IF data with A549 cells IF data with A549 cells IHC data for human carcinoma liver tissue
  • 15. Immunoassay Development Quantitation of 6 Growth Factors in an 11-plex ELISA 30000 FGF -4 25000 Median Fluorescent Intensity VEGF -D EGF 20000 HGF PlGF 15000 VEGF -A 10000 5000 0 1 10 100 1000 10000 Analyte Concentration (pg/ml)
  • 16. Summary  OriGene has developed the most comprehensive genome wide product solutions available  Leading developer of high quality reagents and multiplex assays for every human protein  OriGene is your perfect partner for companion diagnostic and biomarker assay development  Additional information available at: www.origene.com